MariMed Inc. (MRMD)
(Delayed Data from OTC)
$0.16 USD
0.00 (2.42%)
Updated Oct 20, 2025 03:59 PM ET
3-Hold of 5 3
A Value B Growth A Momentum A VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
MRMD 0.16 0.00(2.42%)
Will MRMD be a Portfolio Killer in October?
Zacks Investment Research is releasing its prediction for MRMD based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for MRMD
MariMed Inc. (MRMD) Upgraded to Strong Buy: What Does It Mean for the Stock?
Fast-paced Momentum Stock MariMed Inc. (MRMD) Is Still Trading at a Bargain
MRMD: What are Zacks experts saying now?
Zacks Private Portfolio Services
Why Fast-paced Mover MariMed Inc. (MRMD) Is a Great Choice for Value Investors
Zacks Industry Outlook Highlights Envista, BioLife Solutions, InfuSystems and MariMed
Despite Fast-paced Momentum, MariMed Inc. (MRMD) Is Still a Bargain Stock
Other News for MRMD
MSOS: Cannabis Investors Betting Big On Trump
Trump reportedly considering reclassifying marijuana to less dangerous status
MariMed Inc (MRMD) Q2 2025 Earnings Call Highlights: Navigating Growth Amid Industry Challenges
Q2 2025 MariMed Inc Earnings Call Transcript
MariMed signals expansion into Pennsylvania and Maine while strengthening brand presence after Q2 revenue reaches $39.6M